Migraine. Migraine
Conditions
Interventions
Intervention 1: Intervention group: Consumption of propranolol (Tolid Daroo, Pharmaceutical) with dosage 1 mg/kg divided into 2 doses along 250 mg Yumogi capsule from Yomogi company for 2 months. Inte
Sponsors
Hamedan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
5 Years to 15 Years
Inclusion criteria
Inclusion criteria: Children aged 5 to 15 years A definitive diagnosis of migraine disease by a neurologist Family consent to attend the project Suitable for the onset of migraine prophylaxis: (leading to school absenteeism or dysfunction, PEDMIDAS of more than 20)
Exclusion criteria
Exclusion criteria: Other types of headaches, including chronic or drug-related headaches Inflammatory bowel disease Having neurological disorders Use of antibiotics for 2 months before the start of the study Use of probiotic supplements 2 weeks before the start of the study. Prohibition of propranolol in patients such as asthma and diabetes.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Monthly frequency of headache. Timepoint: Before and two months after treatment. Method of measurement: Asking from patient.;Severity of headache. Timepoint: Before and two months after treatment. Method of measurement: Asking from patient.;Pediatric Migraine Disability score. Timepoint: Before and two months after treatment. Method of measurement: Asking from patient. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactBentolhoda Keshtkar Sohi
Hamedan University of Medical Sciences
Outcome results
None listed